BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 19188825)

  • 1. A pilot evaluation of a novel immunohistochemical assay for topoisomerase II-alpha and minichromosome maintenance protein 2 expression (ProEx C) in cervical adenocarcinoma in situ, adenocarcinoma, and benign glandular mimics.
    Aximu D; Azad A; Ni R; Colgan T; Nanji S
    Int J Gynecol Pathol; 2009 Mar; 28(2):114-9. PubMed ID: 19188825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of a novel immunocytochemical assay for topoisomerase II-alpha and minichromosome maintenance protein 2 expression in cervical cytology.
    Shroyer KR; Homer P; Heinz D; Singh M
    Cancer; 2006 Oct; 108(5):324-30. PubMed ID: 16937378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BD ProEx C: a sensitive and specific marker of HPV-associated squamous lesions of the cervix.
    Badr RE; Walts AE; Chung F; Bose S
    Am J Surg Pathol; 2008 Jun; 32(6):899-906. PubMed ID: 18425044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of p16ink4a, ProEX C, and Ki-67 for the diagnosis of glandular dysplasia and adenocarcinoma of the cervix uteri.
    Negri G; Bellisano G; Carico E; Faa G; Kasal A; Antoniazzi S; Egarter-Vigl E; Piccin A; Dalla Palma P; Vittadello F
    Int J Gynecol Pathol; 2011 Jul; 30(4):407-13. PubMed ID: 21623205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of ProExC: a novel immunoperoxidase marker in the evaluation of dysplastic squamous and glandular lesions in cervical specimens.
    Sanati S; Huettner P; Ylagan LR
    Int J Gynecol Pathol; 2010 Jan; 29(1):79-87. PubMed ID: 19952938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical patterns of ProEx C in vulvar squamous lesions: detection of overexpression of MCM2 and TOP2A.
    Chen H; Gonzalez JL; Brennick JB; Liu M; Yan S
    Am J Surg Pathol; 2010 Sep; 34(9):1250-7. PubMed ID: 20697251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of ProEx C with p16INK4a and Ki-67 immunohistochemical staining of cell blocks prepared from residual liquid-based cervicovaginal material: a pilot study.
    Halloush RA; Akpolat I; Jim Zhai Q; Schwartz MR; Mody DR
    Cancer; 2008 Dec; 114(6):474-80. PubMed ID: 19016301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of human papillomavirus on cell cycle-related proteins p16, Ki-67, Cyclin D1, p53, and ProEx C in precursor lesions of cervical carcinoma: a tissue microarray study.
    Conesa-Zamora P; Doménech-Peris A; Orantes-Casado FJ; Ortiz-Reina S; Sahuquillo-Frías L; Acosta-Ortega J; García-Solano J; Pérez-Guillermo M
    Am J Clin Pathol; 2009 Sep; 132(3):378-90. PubMed ID: 19687314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarker (ProEx C, p16(INK4A), and MiB-1) distinction of high-grade squamous intraepithelial lesion from its mimics.
    Pinto AP; Schlecht NF; Woo TY; Crum CP; Cibas ES
    Mod Pathol; 2008 Sep; 21(9):1067-74. PubMed ID: 18552822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and clinical validation of MCM2 and TOP2A monoclonal antibodies in the BD ProEx™ C assay: An immunoassay which detects aberrant S-phase induction in cervical tissue.
    Dixon EP; King LM; Nelson R; Simkins SG; Knapp SL; Brough GH; Lenz KL; Henderson DT; Whitehead CM; Hessling J; Brown CA; Malinowski DP
    J Immunol Methods; 2017 Mar; 442():35-41. PubMed ID: 28093271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of cervical high-grade squamous intraepithelial lesions from cytologic samples using a novel immunocytochemical assay (ProEx C).
    Kelly D; Kincaid E; Fansler Z; Rosenthal DL; Clark DP
    Cancer; 2006 Dec; 108(6):494-500. PubMed ID: 17063495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detecting high-grade cervical disease on ASC-H cytology: role of BD ProEx C and Digene Hybrid Capture II HPV DNA testing.
    Siddiqui MT; Cohen C; Nassar A
    Am J Clin Pathol; 2008 Nov; 130(5):765-70. PubMed ID: 18854269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of p16INK4a, minichromosome maintenance protein 2, DNA topoisomerase IIalpha, ProEx C, and p16INK4a/ProEx C in cervical squamous intraepithelial lesions.
    Boucher J; Anku-Bertholet C; Temmar R; Pelmus M
    Hum Pathol; 2009 Jun; 40(6):904-5; author reply 905-6. PubMed ID: 19442790
    [No Abstract]   [Full Text] [Related]  

  • 14. p16(INK4a) and ProEx C immunostains facilitate differential diagnosis of hyperchromatic crowded groups in liquid-based Papanicolaou tests with menstrual contamination.
    Ge Y; Mody DR; Smith D; Anton R
    Acta Cytol; 2012; 56(1):55-61. PubMed ID: 22236746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative detection of molecular markers ProEx C (minichromosome maintenance protein 2 and topoisomerase IIa) and MIB-1 in liquid-based cervical squamous cell cytology.
    Beccati MD; Buriani C; Pedriali M; Rossi S; Nenci I
    Cancer; 2008 Jun; 114(3):196-203. PubMed ID: 18442059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ProEx C immunocytochemistry and high-risk human papillomavirus DNA testing in papanicolaou tests with atypical squamous cell (ASC-US) cytology: correlation study with histologic biopsy.
    Siddiqui MT; Hornaman K; Cohen C; Nassar A
    Arch Pathol Lab Med; 2008 Oct; 132(10):1648-52. PubMed ID: 18834224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical staining with MIB1, bcl2 and p16 assists in the distinction of cervical glandular intraepithelial neoplasia from tubo-endometrial metaplasia, endometriosis and microglandular hyperplasia.
    Cameron RI; Maxwell P; Jenkins D; McCluggage WG
    Histopathology; 2002 Oct; 41(4):313-21. PubMed ID: 12383213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclin D1 immunoreactivity in normal endocervix and diagnostic value in reactive and neoplastic endocervical lesions.
    Little L; Stewart CJ
    Mod Pathol; 2010 Apr; 23(4):611-8. PubMed ID: 20062011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Keratin 17 Is a Prognostic Biomarker in Endocervical Glandular Neoplasia.
    Mockler D; Escobar-Hoyos LF; Akalin A; Romeiser J; Shroyer AL; Shroyer KR
    Am J Clin Pathol; 2017 Sep; 148(3):264-273. PubMed ID: 28821199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucinous expression in benign and neoplastic glandular lesions of the uterine cervix.
    Baker AC; Eltoum I; Curry RO; Stockard CR; Manne U; Grizzle WE; Chhieng D
    Arch Pathol Lab Med; 2006 Oct; 130(10):1510-5. PubMed ID: 17090193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.